Cheracol-D Side Effects
Generic name: dextromethorphan / guaifenesin
Note: This document contains side effect information about dextromethorphan / guaifenesin. Some of the dosage forms listed on this page may not apply to the brand name Cheracol-D.
Some side effects of Cheracol-D may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to dextromethorphan / guaifenesin: capsules, elixir, extended-release liquid, extended-release tablets, granule packets, liquid, solution, suspension, sustained-release tablets, syrup, tablets
Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Seek medical attention right away if any of these SEVERE side effects occur while taking dextromethorphan / guaifenesin:
Dizziness; drowsiness; stomach upset.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue).
For Healthcare Professionals
Applies to dextromethorphan / guaifenesin: oral capsule, oral capsule extended release, oral elixir, oral granule, oral liquid, oral suspension extended release, oral tablet, oral tablet extended release
Nervous system side effects of dextromethorphan have included drowsiness and dizziness. Adverse effects, which have occurred at higher doses, include excitation, mental confusion, and opioid like respiratory depression. In some cases of abuse, patients have experienced euphoria, hyperactivity, mania, and auditory and visual hallucinations.
Gastrointestinal side effects have included nausea, vomiting and constipation.
Dermatologic side effects have included pruritus and rash.
Hypersensitivity side effects of dextromethorphan have included fixed-drug eruptions.
More Cheracol-D resources
- Cheracol-D Concise Consumer Information (Cerner Multum)
- Atuss-12 DX extended-release liquid MedFacts Consumer Leaflet (Wolters Kluwer)
- Bidex-A extended-release tablets MedFacts Consumer Leaflet (Wolters Kluwer)
- Duratuss DM 12 suspension MedFacts Consumer Leaflet (Wolters Kluwer)
- Guaifenesin DM Elixir MedFacts Consumer Leaflet (Wolters Kluwer)
- Humibid CS MedFacts Consumer Leaflet (Wolters Kluwer)
- Mucinex DM Prescribing Information (FDA)
- Mucinex DM Maximum Strength Prescribing Information (FDA)
- Robitussin DM infant drops
- Scot-Tussin DM liquid MedFacts Consumer Leaflet (Wolters Kluwer)
- Tussin DM Prescribing Information (FDA)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.